BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 29190176)

  • 21. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum ferritin levels and irregular use of iron chelators predict liver iron load in patients with major beta thalassemia: a cross-sectional study.
    Sobhani S; Rahmani F; Rahmani M; Askari M; Kompani F
    Croat Med J; 2019 Oct; 60(5):405-413. PubMed ID: 31686454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of heart and liver iron deposition status in patients with β- thalassemia intermedia and major with MRI T2* technique].
    Li CG; Liu SX; Mai HR; Wang Y; Wen FQ; Liu RY; Zhang XH; Chu WC; Au WY
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Feb; 14(2):110-3. PubMed ID: 22357467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI for Quantification of Liver and Cardiac Iron in Thalassemia Major Patients: Pilot Study in Indian Population.
    Mandal S; Sodhi KS; Bansal D; Sinha A; Bhatia A; Trehan A; Khandelwal N
    Indian J Pediatr; 2017 Apr; 84(4):276-282. PubMed ID: 28233255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of Serum Ferritin and Liver Iron Concentration with Transient Liver Elastography in Adult Thalassemia Intermedia Patients with Blood Transfusion.
    Atmakusuma TD; Lubis AM
    J Blood Med; 2021; 12():235-243. PubMed ID: 33883962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between myocardial T2 values and cardiac volumetric and functional parameters in β-thalassemia patients evaluated by cardiac magnetic resonance in association with serum ferritin levels.
    Liguori C; Pitocco F; Di Giampietro I; de Vivo AE; Schena E; Cianciulli P; Zobel BB
    Eur J Radiol; 2013 Sep; 82(9):e441-7. PubMed ID: 23639773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low prevalence of cardiac siderosis in heavily iron loaded Egyptian thalassemia major patients.
    El Beshlawy A; El Tagui M; Hamdy M; El Ghamrawy M; Azim KA; Salem D; Said F; Samir A; St Pierre T; Pennell DJ
    Ann Hematol; 2014 Mar; 93(3):375-9. PubMed ID: 23949317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major.
    Mokhtar GM; Sherif EM; Habeeb NM; Abdelmaksoud AA; El-Ghoroury EA; Ibrahim AS; Hamed EM
    Hematology; 2016 Jan; 21(1):46-53. PubMed ID: 26288192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of HFE Gene Mutations With Serum Ferritin Level and Heart and Liver Iron Overload in Patients With Transfusion-dependent Beta-Thalassemia.
    Zekavat OR; Zareian Jahromi M; Haghpanah S; Kargar Jahromi Z; Cohan N
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e26-e28. PubMed ID: 32925401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of severe liver iron overload for assessing heart iron levels in thalassemia major patients.
    Chen X; Zhang H; Yang Q; Luo Z; Zhang Z; Cheng Z; Mao J; Chan Q; Xu H; Liang B; Guo H
    J Magn Reson Imaging; 2016 Oct; 44(4):880-9. PubMed ID: 27038128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pantoprazole reduces serum ferritin in patients with thalassemia major and intermedia: A randomized, controlled study.
    Eghbali A; Khalilpour A; Taherahmadi H; Bagheri B
    Therapie; 2019 Oct; 74(5):507-512. PubMed ID: 30704764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P; Giua R; De Marco S; Bonetti MG; Amurri B; Masi C; Lazzari G; Rizzo C; Cervellera M; Peluso A
    Haematologica; 1995; 80(5):398-404. PubMed ID: 8566878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal iron deposition by magnetic resonance imaging in pediatric β-thalassemia major patients: Relation to renal biomarkers, total body iron and chelation therapy.
    ElAlfy MS; Khalil Elsherif NH; Ebeid FSE; Ismail EAR; Ahmed KA; Darwish YW; Ibrahim AS; Elghamry IRF; Shokrey NA; Alajeil DN
    Eur J Radiol; 2018 Jun; 103():65-70. PubMed ID: 29803388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deferiprone as an oral iron chelator in sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Stamoulakatou A; Meletis J; Ourailidis A; Papassotiriou I; Loukopoulos D
    Ann Hematol; 2005 Jul; 84(7):434-40. PubMed ID: 15809885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging in the evaluation of iron overload: a comparison of MRI, echocardiography and serum ferritin level in patients with β-thalassemia major.
    Shamsian BS; Esfahani SA; Milani H; Akhlaghpoor S; Mojtahedzadeh S; Karimi A; Shamshiri AR; Alavi S; Safari A; Rezaei N; Arzanian MT
    Clin Imaging; 2012; 36(5):483-8. PubMed ID: 22920350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
    Said Othman KM; Elshazly SA; Heiba NM
    Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interrelationship between liver T2*-weighted magnetic resonance imaging and acoustic radiation force impulse elastography measurement results and plasma ferritin levels in children with β-thalassemia major.
    Kaban S; Damar Ç
    J Clin Ultrasound; 2022 Jan; 50(1):108-116. PubMed ID: 34716933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major.
    Kirk P; Roughton M; Porter JB; Walker JM; Tanner MA; Patel J; Wu D; Taylor J; Westwood MA; Anderson LJ; Pennell DJ
    Circulation; 2009 Nov; 120(20):1961-8. PubMed ID: 19801505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of Liver Iron Load in Adult Patients with β-Thalassemia Major Treated with Modern Chelation Modalities.
    Georgiev PG; Sapunarova KG; Goranova-Marinova VS; Goranov SE
    Folia Med (Plovdiv); 2020 Jun; 62(2):265-270. PubMed ID: 32666765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.